Galectin Therapeutics Analyst Ratings
Galectin Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 638.26% | HC Wainwright & Co. | $11 → $11 | Reiterates | Buy → Buy |
| 05/17/2023 | 638.26% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 03/03/2023 | 638.26% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 05/17/2022 | 638.26% | HC Wainwright & Co. | $14 → $11 | Maintains | Buy |
| 04/16/2021 | 839.6% | HC Wainwright & Co. | $12 → $14 | Maintains | Buy |
| 08/13/2020 | 705.37% | HC Wainwright & Co. | $9 → $12 | Maintains | Buy |
| 04/03/2020 | 168.46% | B. Riley Securities | $8 → $4 | Maintains | Buy |
| 03/17/2020 | 504.03% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
| 02/13/2019 | 638.26% | B. Riley Securities | → $11 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/15/2023 | 638.26% | HC Wainwright & Co. | 11 美元 → 11 美元 | 重申 | 购买 → 购买 |
| 05/17/2023 | 638.26% | HC Wainwright & Co. | → 11 美元 | 重申 | 购买 → 购买 |
| 03/03/2023 | 638.26% | HC Wainwright & Co. | → 11 美元 | 重申 | → 购买 |
| 05/17/2022 | 638.26% | HC Wainwright & Co. | 14 美元 → 11 美元 | 维护 | 购买 |
| 2021 年 4 月 16 日 | 839.6% | HC Wainwright & Co. | 12 美元 → 14 美元 | 维护 | 购买 |
| 08/13/2020 | 705.37% | HC Wainwright & Co. | 9 美元 → 12 美元 | 维护 | 购买 |
| 2020 年 3 月 4 日 | 168.46% | B. 莱利证券 | 8 美元 → 4 美元 | 维护 | 购买 |
| 03/17/2020 | 504.03% | HC Wainwright & Co. | 11 美元 → 9 美元 | 维护 | 购买 |
| 02/13/2019 | 638.26% | B. 莱利证券 | → 11 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Galectin Therapeutics (GALT)?
Galectin Therapeutics（GALT）的目标价格是多少？
The latest price target for Galectin Therapeutics (NASDAQ: GALT) was reported by HC Wainwright & Co. on August 15, 2023. The analyst firm set a price target for $11.00 expecting GALT to rise to within 12 months (a possible 638.26% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月15日公布了Galectin Therapeutics（纳斯达克股票代码：GALT）的最新目标股价。这家分析公司将目标股价定为11.00美元，预计GALT将在12个月内升至12个月内（可能上涨638.26％）。去年有3家分析公司公布了评级。
What is the most recent analyst rating for Galectin Therapeutics (GALT)?
分析师对Galectin Therapeutics（GALT）的最新评级是多少？
The latest analyst rating for Galectin Therapeutics (NASDAQ: GALT) was provided by HC Wainwright & Co., and Galectin Therapeutics reiterated their buy rating.
Galectin Therapeutics（纳斯达克股票代码：GALT）的最新分析师评级由HC Wainwright & Co. 提供，Galectin Therapeutics重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Galectin Therapeutics (GALT)?
Galectin Therapeutics（GALT）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Galectin Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Galectin Therapeutics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Galectin Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Galectin Therapeutics的最新评级是在2023年8月15日提交的，因此你应该预计下一个评级将在2024年8月15日左右公布。
Is the Analyst Rating Galectin Therapeutics (GALT) correct?
分析师对Galectin Therapeutics（GALT）的评级正确吗？
While ratings are subjective and will change, the latest Galectin Therapeutics (GALT) rating was a reiterated with a price target of $11.00 to $11.00. The current price Galectin Therapeutics (GALT) is trading at is $1.49, which is out of the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Galectin Therapeutics（GALT）评级得到了重申，目标股价为11.00美元至11.00美元。Galectin Therapeutics（GALT）目前的交易价格为1.49美元，超出了分析师的预测区间。